Business Description
AcelRx Pharmaceuticals Inc
NAICS : 325411
SIC : 2833
Compare
Compare
Traded in other countries / regions
R5XA.GermanyACRX.USA IPO Date
2011-02-11Description
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.28 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | 0.25 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -8.39 | |||||
| Beneish M-Score | 21.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -13.9 | |||||
| 3-Year EBITDA Growth Rate | 23.8 | |||||
| 3-Year EPS without NRI Growth Rate | 29 | |||||
| 3-Year FCF Growth Rate | 19.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.93 | |||||
| 9-Day RSI | 25.18 | |||||
| 14-Day RSI | 23.47 | |||||
| 6-1 Month Momentum % | -71.04 | |||||
| 12-1 Month Momentum % | -78.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.57 | |||||
| Quick Ratio | 1.51 | |||||
| Cash Ratio | 1.02 | |||||
| Days Inventory | 115.67 | |||||
| Days Sales Outstanding | 65.9 | |||||
| Days Payable | 241.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -127.68 | |||||
| Operating Margin % | -2135.04 | |||||
| Net Margin % | 3111.24 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 72.45 | |||||
| ROIC % | -94 | |||||
| ROC (Joel Greenblatt) % | 256.88 | |||||
| ROCE % | 101.34 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.11 | |||||
| PE Ratio without NRI | 0.11 | |||||
| Price-to-Owner-Earnings | 0.12 | |||||
| PEG Ratio | 0.01 | |||||
| PS Ratio | 3.38 | |||||
| PB Ratio | 0.19 | |||||
| Price-to-Tangible-Book | 0.28 | |||||
| EV-to-EBIT | 0.04 | |||||
| EV-to-EBITDA | 0.04 | |||||
| EV-to-Revenue | 1.37 | |||||
| EV-to-Forward-Revenue | 0.13 | |||||
| EV-to-FCF | -0.07 | |||||
| Price-to-Median-PS-Value | 0.15 | |||||
| Price-to-Graham-Number | 0.04 | |||||
| Price-to-Net-Current-Asset-Value | 1.49 | |||||
| Earnings Yield (Greenblatt) % | 2500 |
How AcelRx Pharmaceuticals Inc (ACRX) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACRX
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.521 | ||
| EPS (TTM) ($) | 6.26 | ||
| Beta | -0.26 | ||
| Volatility % | 76.16 | ||
| 14-Day RSI | 23.47 | ||
| 14-Day ATR ($) | 0.136894 | ||
| 20-Day SMA ($) | 1.00838 | ||
| 12-1 Month Momentum % | -78.55 | ||
| 52-Week Range ($) | 0.5687 - 7.6 | ||
| Shares Outstanding (Mil) | 7.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AcelRx Pharmaceuticals Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
AcelRx Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AcelRx Pharmaceuticals Inc Frequently Asked Questions
What is AcelRx Pharmaceuticals Inc(ACRX)'s stock price today?
The current price of ACRX is $0.70. The 52 week high of ACRX is $7.60 and 52 week low is $0.57.
When is next earnings date of AcelRx Pharmaceuticals Inc(ACRX)?
The next earnings date of AcelRx Pharmaceuticals Inc(ACRX) is 2023-05-16 Est..
Does AcelRx Pharmaceuticals Inc(ACRX) pay dividends? If so, how much?
AcelRx Pharmaceuticals Inc(ACRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
